INVO Fertility (IVF) Change in Accured Expenses (2011 - 2026)

INVO Fertility (IVF) has 16 years of Change in Accured Expenses data on file, last reported at $64011.0 in Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 906.46% year-over-year to $64011.0 in Q1 2026; TTM through Mar 2026 was -$935989.0, a 205.77% decrease from a year earlier, with the FY2024 full-year figure at $1.4 million, up 696.15% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $64011.0, up from -$310893.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for IVF reached as high as $1.3 million in Q4 2024 and fell as low as -$703570.0 in Q4 2023.
• Historically, Change in Accured Expenses has averaged $34543.2 across 5 years, with a median of $39490.5 in 2022.
• On a YoY basis, Change in Accured Expenses climbed as much as 1360.54% in 2023 and fell as far as 694.05% in 2023.
• Year by year, Change in Accured Expenses stood at $118437.0 in 2022, then plunged by 694.05% to -$703570.0 in 2023, then jumped by 278.38% to $1.3 million in 2024, then tumbled by 124.77% to -$310893.0 in 2025, then jumped by 120.59% to $64011.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $64011.0 in Q1 2026, -$310893.0 in Q3 2025, and -$695467.0 in Q2 2025.